More Yasmin birth control lawsuits have been filed against Bayer, alleging the contraception is linked to serious side effects. Bayer has put money aside to settle Yasmin and Yaz side effects lawsuits, but women are still coming forward alleging they were not adequately warned about the risks associated with the birth control. Studies, including a study commissioned by the FDA, show that Yasmin and Yaz are linked to an increased risk of blood clots because of the use of drospirenone. A study published in the journal IBMJ found that women who used birth control that included drospirenone — a synthetic version of progesterone (which is sometimes referred to as progestin) — had double the risk of blood clots as women using other oral contraceptives.
We have learned during the litigation handled by lawyers in our firm that Bayer failed to properly test the contraceptives before selling them and then failed to warn the public or medical professionals about the risks associated with using Yaz and Yasmin. Bayer also produced television commercials that marketed Yaz and Yasmin as being safer than other forms of birth control that were available when in fact they were not safer.
Bayer has so far paid a reported $402 million to settle Yaz and Yasmin lawsuits, while setting aside another $600 million for future settlements. Approximately 11,000 lawsuits, filed in federal multidistrict litigation, are consolidated in the Southern District of Illinois. Some of those lawsuits allege Plaintiffs suffered blood clots while others allege the Plaintiffs suffered gall bladder problems.
Bellwether trials for Yaz, Yasmin and Ocella were scheduled to go to court earlier in 2012, but the sides sought mediation, resulting in settlements in at least some of the lawsuits. Although settlements have been reached in blood clot lawsuits, so far there have been no settlements of gall bladder claims to my knowlege. In April 2012, the FDA ordered Bayer to increase the warnings on Yaz and Yasmin, to more adequately represent the risk of blood clots. That announcement was made following an FDA review of studies comparing the risk of blood clots between birth controls that contained drospirenone and those that did not.
Some studies found up to three times the risk of blood clots in women who used drospirenone-containing birth control. Even though some settlements have been announced, it is not too late for women who suffered health problems after using Yaz, Yasmin or Ocella to file a lawsuit, providing the statute of limitations has not run out. If you need more information, contact Roger Smith, a lawyer in our Mass Torts Section, at 800-898-2034 or by email at Roger.Smith@beasleyallen.com.
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.